Pet Medications Market Overview: United States Report

Report Overview

This report forecasts US pet medication retail sales in nominal US dollars for 2025-2030. To illustrate historical trends, total retail sales are provided in annual series from 2020-2025.
This report provides a general overview of the retail market for medications for domesticated dogs and cats, with a focus on products purchased directly by consumers. These include both prescription and over-the-counter (also called OTC or retail) medications. The primary focus of this report is on the core types of antiparasitics/ parasiticides – heartworm preventatives, flea/tick preventatives, and heartworm/flea combo products, and other dewormers (some of which also target other external parasites such as mosquitoes, flies, ear mites, lice, and sarcoptic mange, and/or other types of internal parasites such as hookworms, roundworms, whipworms, and tapeworms). “Flea/tick” can refer to products that treat only fleas and ticks, but can also refer to combination products that additionally treat worms, mites, etc., except heartworms. Also covered are market-shaping developments in other areas, including anxiety, pain management, cancer, cognitive dysfunction, and obesity/diabetes.
Animal health products for production animals and horses are excluded from this market analysis, as are nutritional supplements for companion animals, which are covered in Packaged Facts’ March 2026 report Pet Supplements in the US.
A full outline of report items by page is available in the Table of Contents.

Related NAICS Codes

Table of Contents

• US Retail Sales
• Sales by Animal Type
• Sales by Channel
• Sales by Product Type

• Economy’s Impact on Pet Owner Spending
• Changes in US Pet Population
• Pet Health & Wellness
• Pet Medication & Vet Usage
• Competition from Supplements & Foods

• Scope
• Sources
• Industry Codes
• Resources

• Table 1 | US Retail Sales of Pet Medications, 2020 – 2025 (US$ mil)
• Table 2 | Projected US Retail Sales of Pet Medications, 2025 – 2030P (US$ mil)
• Figure 1 | Share of US Retail Sales of Pet Medications by Animal Type: Dog vs. Cat, 2025 (%)
• Table 3 | Share of US Retail Sales of Pet Medications by Distribution Channel, 2025 (US$ mil & share)
• Table 4 | Share of US Retail Sales of Pet Medications by Product Type, 2025 (US$ mil & share)
• Figure 2 | Reduction in Spending on “Extras”, 2026 (% of pet owners)
• Table 5 | Ratio of Puppy to Kitten Households, 2020/21-2024/25
• Table 6 | NAICS & SIC Codes Related to Pet Medications